Status:
COMPLETED
Modification of Goal-directed and Habitual Behavior in Addiction
Lead Sponsor:
Central Institute of Mental Health, Mannheim
Conditions:
Tobacco Use Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study aims to examine the modification of the hypothesized imbalance between goal-directed and habitual behavior and its neural correlates in smokers. Two interventions will be used as add-on tra...
Detailed Description
In this study, the investigators aim to assess the imbalance between goal-directed and habitual behavior, its neural basis and how it can be differentially modified in treatment-seeking smokers, using...
Eligibility Criteria
Inclusion
- severe tobacco use disorder (TUD) according to DSM-5
- sufficient ability to communicate with investigators and answer questions in both written and verbal format
- ability to provide fully informed consent and to use self-rating scales
Exclusion
- severe internal, neurological, and/or psychiatric comorbidities; other Axis I mental disorders other than TUD according to ICD-10 and DSM 5 (except for mild depression, i.e. F32.0, adjustment disorder and specific phobias) in the last 12 months
- history of brain injury
- severe physical diseases
- common exclusion criteria for MRI (e.g. metal, claustrophobia)
- positive drug screening (opioids, benzodiazepines, barbiturates, cocaine, amphetamines)
- psychotropic medication within the last 14 days
- pregnancy
Key Trial Info
Start Date :
January 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 23 2023
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03764969
Start Date
January 7 2020
End Date
June 23 2023
Last Update
October 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit
Mannheim, Baden-Wurttemberg, Germany, 68159